Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial

Effectiveness of benralizumab in the Tokyo Asthma Study (TOAST): A real-world prospective interventional trial

Background: Biologics are integral in the management of severe asthma. As the effectiveness of the anti-IL-5 receptor antibody benralizumab in Japan remains elusive, this study aimed to assess its real-world effectiveness in Japanese patients with severe asthma. Methods: This prospective, interventi...

Full description

Saved in:
Bibliographic Details
Main Authors: Katsunori Masaki, Maho Suzukawa, Hitoshi Sasano, Norihiro Harada, Yasunari Miyazaki, Hideki Katsura, Etsuko Tagaya, Junko Terada, Masayuki Hojo, Naoya Sugimoto, Hiroyuki Nagase, Yuta Kono, Hisato Hiranuma, Yasuhiro Gon, Ryo Takemura, Misato Irie, Reina Nakamura, Hiroki Kabata, Jun Miyata, Koichi Fukunaga
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Allergology International
Subjects:
Anti-IL-5 receptor antibody
Asthma control questionnaire
Eosinophils
Responder
Severe asthma
Online Access:http://www.sciencedirect.com/science/article/pii/S132389302400128X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S132389302400128X

Similar Items